当前位置: X-MOL 学术J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Exploratory phase I study of HF1K16 for the treatment of patients with refractory/recurrent advanced glioma: Preliminary efficacy and mechanism as a monotherapy.
Journal of Clinical Oncology ( IF 42.1 ) Pub Date : 2024-05-29 , DOI: 10.1200/jco.2024.42.16_suppl.e14030
Ruofan Huang 1 , Anjie Zheng 2 , Yuhong Xu 3 , Xiaochen Zhang 4 , Jinsong Wu 1
Affiliation  

Journal of Clinical Oncology, Volume 42, Issue 16_suppl, Page e14030-e14030, June 2024.


中文翻译:


HF1K16 治疗难治性/复发性晚期胶质瘤患者的探索性 I 期研究:作为单一疗法的初步疗效和机制。



《临床肿瘤学杂志》,第 42 卷,第 16 期_suppl,第 e14030-e14030 页,2024 年 6 月。
更新日期:2024-05-30
down
wechat
bug